Marimed (MRMD) Gross Margin (2011 - 2026)

Marimed (MRMD) has 16 years of Gross Margin data on file, last reported at 38.69% in Q1 2026.

• Gross Margin for Q1 2026 came in at 38.69%, down 111.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 36.02% (down 289.0% YoY), and the FY2025 annual result was 36.22%, down 349.0% from the prior year.
• Gross Margin improved to 38.69% in Q1 2026 per MRMD's latest filing, from 25.21% in the prior quarter.
• Over five years, Gross Margin peaked at 54.27% in Q1 2022 and troughed at 25.21% in Q4 2025.
• A 5-year average of 41.91% and a median of 43.4% in 2023 frame the typical range for Gross Margin.
• On a YoY basis, Gross Margin climbed as much as 76 bps in 2022 and fell as far as 1410 bps in 2022.
• A 5-year view of Gross Margin shows it stood at 44.13% in 2022, then climbed by 1 bps to 44.52% in 2023, then fell by 27 bps to 32.49% in 2024, then dropped by 22 bps to 25.21% in 2025, then jumped by 53 bps to 38.69% in 2026.
• Business Quant data shows MRMD's Gross Margin at 38.69% in Q1 2026, 25.21% in Q4 2025, and 40.14% in Q3 2025.